Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tullio Florio

Showing results (151-160 of 180) with videos related to

Pageof 18
Sort By:
Oncotarget|November 1, 2014
Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion currentMarta Gritti, Roberto Würth, Marina Angelini, et al.
International Journal of Molecular Sciences|October 13, 2021
N6-Isopentenyladenosine Hinders the Vasculogenic Mimicry in Human Glioblastoma Cells through Src-120 Catenin Pathway Modulation and RhoA Activity InhibitionCristina Pagano, Giovanna Navarra, Olga Pastorino, et al.
Cancers|April 30, 2021
Octreotide and Pasireotide Combination Treatment in Somatotroph Tumor Cells: Predominant Role of SST<sub>2</sub> in Mediating Ligand EffectsJessica Amarù, Federica Barbieri, Marica Arvigo, et al.
Scientific Reports|March 4, 2018
Development of an Injectable Slow-Release Metformin Formulation and Evaluation of Its Potential Antitumor EffectsSara Baldassari, Agnese Solari, Guendalina Zuccari, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 30, 2002
Isolation of a long-lasting eag-related gene-type K+ current in MMQ lactotrophs and its accommodating role during slow firing and prolactin releaseMarzia Lecchi, Elisa Redaelli, Barbara Rosati, et al.
Clinical Endocrinology|August 19, 2011
Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogues and dopastatinsFederico Gatto, Federica Barbieri, Monica Gatti, et al.
Clinical Endocrinology|June 17, 2003
Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitroTullio Florio, Stefano Thellung, Alessandro Corsaro, et al.
Experimental Cell Research|January 7, 2018
In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivityMonica Gatti, Agnese Solari, Alessandra Pattarozzi, et al.
Oncotarget|December 29, 2016
The inhibition of 45A ncRNA expression reduces tumor formation, affecting tumor nodules compactness and metastatic potential in neuroblastoma cellsIlaria Penna, Arianna Gigoni, Delfina Costa, et al.
Cell Cycle (Georgetown, Tex.)|December 21, 2012
Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of AktRoberto Würth, Alessandra Pattarozzi, Monica Gatti, et al.
Pageof 18

Showing results (151-160 of 180) with videos related to

Sort By:
Pageof 18
Oncotarget|November 1, 2014
Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion currentMarta Gritti, Roberto Würth, Marina Angelini, et al.
International Journal of Molecular Sciences|October 13, 2021
N6-Isopentenyladenosine Hinders the Vasculogenic Mimicry in Human Glioblastoma Cells through Src-120 Catenin Pathway Modulation and RhoA Activity InhibitionCristina Pagano, Giovanna Navarra, Olga Pastorino, et al.
Cancers|April 30, 2021
Octreotide and Pasireotide Combination Treatment in Somatotroph Tumor Cells: Predominant Role of SST<sub>2</sub> in Mediating Ligand EffectsJessica Amarù, Federica Barbieri, Marica Arvigo, et al.
Scientific Reports|March 4, 2018
Development of an Injectable Slow-Release Metformin Formulation and Evaluation of Its Potential Antitumor EffectsSara Baldassari, Agnese Solari, Guendalina Zuccari, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 30, 2002
Isolation of a long-lasting eag-related gene-type K+ current in MMQ lactotrophs and its accommodating role during slow firing and prolactin releaseMarzia Lecchi, Elisa Redaelli, Barbara Rosati, et al.
Clinical Endocrinology|August 19, 2011
Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogues and dopastatinsFederico Gatto, Federica Barbieri, Monica Gatti, et al.
Clinical Endocrinology|June 17, 2003
Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitroTullio Florio, Stefano Thellung, Alessandro Corsaro, et al.
Experimental Cell Research|January 7, 2018
In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivityMonica Gatti, Agnese Solari, Alessandra Pattarozzi, et al.
Oncotarget|December 29, 2016
The inhibition of 45A ncRNA expression reduces tumor formation, affecting tumor nodules compactness and metastatic potential in neuroblastoma cellsIlaria Penna, Arianna Gigoni, Delfina Costa, et al.
Cell Cycle (Georgetown, Tex.)|December 21, 2012
Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of AktRoberto Würth, Alessandra Pattarozzi, Monica Gatti, et al.
Pageof 18